Recently, however, the idea of GLP-1 microdosing has gained traction as a potential way to ease into treatment with fewer symptoms
Alcohol: The company's provider guides advise limiting or avoiding alcohol during treatment, especially during dose adjustments, as it may worsen nausea, low blood sugar, or dehydration
Wegovy is approved by the US Food and Drug Administration (FDA) for chronic weight management in adults with a body mass index (BMI) of 30 or higher (classified as obese) or a BMI of 27 or higher (classified as overweight) with at least one weight-related comorbid condition, such as hypertension or type 2 diabetes[1]
As a 503A compounding pharmacy, it operates under state pharmacy board regulation with FDA oversight authority
It's also important to tell them if you are taking GLP-1 medications so they can keep a close watch on your eye health
Exciting to see emerging molecules and new indications like cardiovascular disease, sleep apnea, and even neuropsychiatric disorders